All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital

Rhea-AI Summary

Ping An Biomedical (NASDAQ: PASW) shareholders approved all five AGM resolutions on March 18, 2026, authorizing a comprehensive capital restructure.

Key actions: authorised capital increased to US$312,500 (5,000,000,000 shares), creation of 100,000,000 Class B shares (100 votes each), targeted exchange with INSPIRETECH of 12,250,000 shares, and a conditional 1,000:1 share consolidation to occur within one year.

Positive

• Authorised capital increased to US$312,500 (5,000,000,000 shares)
• Created 100,000,000 Class B shares with 100 votes per share
• Approved targeted conversion: 12,250,000 Class A for 12,250,000 Class B with INSPIRETECH
• Board authorised conditional up to 1,000:1 share consolidation within one year

Negative

• New Class B shares carry 100 votes each, enabling concentrated voting power
• Share consolidation (up to 1,000:1) may substantially reduce outstanding share count and float
• Repurchase/issuance arrangement preserves INSPIRETECH's share count while increasing its voting influence

News Market Reaction – PASW

-5.19%

2 alerts

-5.19% News Effect

-16.8% Trough Tracked

-$1M Valuation Impact

$20M Market Cap

0.1x Rel. Volume

On the day this news was published, PASW declined 5.19%, reflecting a notable negative market reaction. Argus tracked a trough of -16.8% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $1M from the company's valuation, bringing the market cap to $20M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Authorised share capital (before): US$50,000 / 800,000,000 shares Authorised share capital (after): US$312,500 / 5,000,000,000 shares Class A authorised: 4,900,000,000 shares +5 more

8 metrics

Authorised share capital (before) US$50,000 / 800,000,000 shares Pre-AGM authorised capital and ordinary share count

Authorised share capital (after) US$312,500 / 5,000,000,000 shares Post-AGM authorised capital and ordinary share count

Class A authorised 4,900,000,000 shares Authorised Class A ordinary shares after re-designation

Class B authorised 100,000,000 shares New Class B ordinary shares created

Class B voting power 100 votes per share Voting rights attached to each Class B ordinary share

INSPIRETECH swap size 12,250,000 shares Class A repurchased and Class B issued to INSPIRETECH

Share consolidation ratio 1,000:1 Every 1,000 Class A or Class B shares consolidated into 1 share

AGM date Mar 18, 2026 Date on which all five resolutions were approved

Market Reality Check

Price: $0.1379 Vol: Volume 60,528 vs 20-day a...

low vol

$0.1379 Last Close

Volume Volume 60,528 vs 20-day average 420,438, indicating relatively light trading ahead of this AGM news. low

Technical Shares traded below the 200-day MA of 0.47, with the last price at 0.1483, reflecting a depressed longer-term trend.

Peers on Argus

No peer stocks appeared in the momentum scanner and no same-day peer headlines w...

No peer stocks appeared in the momentum scanner and no same-day peer headlines were recorded, so the move in PASW appears stock-specific based on available data.

Historical Context

3 past events · Latest: Jan 09 (Positive)

Pattern 3 events

Date	Event	Sentiment	Move	Catalyst
Jan 09	Strategic investment MOU	Positive	-67.7%	Non-binding memorandum for US$30M initial and US$60M follow-on acquisitions.
Jan 09	New strategic investors	Positive	-67.7%	Share purchase agreements with multiple strategic investors to support growth.
Nov 28	Nasdaq deficiency notice	Negative	-3.6%	Nasdaq minimum bid price deficiency with 180-day compliance window to May 25, 2026.

Pattern Detected

Recent history shows sharp negative moves following strategic investment announcements, while the reaction to a Nasdaq deficiency notice was only modestly negative.

Recent Company History

Over the last several months, Ping An Biomedical reported multiple strategic moves and listing-related updates. On Jan 9, 2026, it announced a non-binding memorandum for an initial US$30 million investment and up to US$60 million in subsequent acquisitions, and separately disclosed new strategic investors. Both news items were followed by -67.65% price reactions. Earlier, on Nov 28, 2025, the company received a Nasdaq minimum bid price deficiency letter tied to the $1.00 requirement, with an initial 180-day cure period ending May 25, 2026. The current AGM-approved share restructuring fits into this broader effort to reposition the capital structure and address listing thresholds.

Market Pulse Summary

The stock moved -5.2% in the session following this news. A negative reaction despite the orderly ap...

Analysis

The stock moved -5.2% in the session following this news. A negative reaction despite the orderly approval of all five AGM resolutions would fit a pattern of volatility seen after prior strategic announcements, including two January 2026 deals that coincided with -67.65% moves. The recapitalization introduces high-vote Class B shares and a potential 1,000:1 consolidation, which can raise governance and liquidity concerns. Investors would focus on how these structural changes affect listing compliance and future capital raises under the new share framework.

Key Terms

authorised share capital, class a ordinary shares, class b ordinary shares, share consolidation, +3 more

7 terms

authorised share capital financial

"Shareholders resolved by an ordinary resolution that, the Company authorised share capital of the Company be amended..."

The maximum number of shares a company is legally allowed to create under its founding documents. Think of it like the size of an empty container: it sets the upper limit on how many ownership pieces the company can hand out, which matters to investors because it controls how easily a company can raise cash, dilute existing owners, or change voting power without a formal legal change.

class a ordinary shares financial

"...re-designating and re-classifying 4,900,000,000 authorised ordinary shares... as 4,900,000,000 class A ordinary shares..."

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

class b ordinary shares financial

"...create a new share class of 100,000,000 class B ordinary shares of par value US$0.0000625 each..."

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

share consolidation financial

"Shareholders resolved by an ordinary resolution that, following the Authorised Share Capital Changes... be consolidated into one (1) class A ordinary share (the Consolidated Class A Share(s))..."

Share consolidation is a process where a company reduces the total number of its shares by combining multiple existing shares into a smaller number of higher-value shares. This can make each share more expensive and potentially improve the company’s image. For investors, it often means their ownership remains the same, but the value of each share increases, which can influence how the stock is perceived and traded.

pari passu financial

"...where such Consolidated Class A Shares shall rank pari passu in all respect with each other..."

An instruction that different claims, securities, or creditors are treated equally and share rights or payments on the same priority level. For investors, it means their position will be paid or have voting power alongside others in the same class rather than being favored or subordinated—think of several people standing in one bus line who all get on together rather than some cutting ahead. That parity affects expected recovery in reorganizations, dividend order, and relative risk.

memorandum and articles of association regulatory

"Shareholders resolved by a special resolution that the second amended and restated memorandum and articles of association of the Company..."

Memorandum and articles of association are the founding legal documents of a company: the memorandum sets out the company’s basic purpose and scope, while the articles act as its internal rulebook detailing how the company is run, who has what powers, and how decisions are made. For investors these documents matter because they define ownership rights, voting rules, limits on activities, and procedures for major changes—like a contract and rulebook that determine how their investment can be used and protected.

proxy statement regulatory

"...attached to the notice of annual general meeting and the proxy statement as Appendix 1..."

A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.

AI-generated analysis. Not financial advice.

HONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that shareholders have approved all five resolutions at the company’s 2026 Annual General Meeting, providing full authorization for an overhaul of its share capital structure, the introduction of high‑vote Class B shares, a targeted share exchange with a major shareholder, and a large‑scale share consolidation.

Authorised Share Capital Changes

Shareholders resolved by an ordinary resolution that, the Company authorised share capital of the Company be amended in the manner and sequence set out below with immediate effect (collectively, the Authorised Share Capital Changes):

(a) increasing the authorised share capital US$50,000 divided into 800,000,000 ordinary shares of a nominal or par value of US$0.0000625 each to US$312,500 divided into 5,000,000,000 ordinary shares of a par value US$0.0000625 each, by the addition of 4,200,000,000 ordinary shares of a par value US$0.0000625 each;

(b) re-designating and re-classifying 4,900,000,000 authorised ordinary shares of a par value US$0.0000625 each (including all existing issued ordinary shares) as 4,900,000,000 class A ordinary shares of par value US$0.0000625 each (the Class A Shares), where the rights of the existing ordinary shares shall be the same as the Class A Shares;

(c) cancelling 100,000,000 authorised but unissued ordinary shares of a par value US$0.0000625 each and create a new share class of 100,000,000 class B ordinary shares of par value US$0.0000625 each (the Class B Shares), which will be entitled to one hundred (100) votes per share,

such that the authorised share capital of the Company shall become US$312,500 divided into 4,900,000,000 class A ordinary shares of a par value US$0.0000625 each and 100,000,000 class B ordinary shares of a par value US$0.0000625 each.

Adoption of Second Amended and Restated Memorandum and Articles of Association

Shareholders resolved by a special resolution that the second amended and restated memorandum and articles of association of the Company, in the substantial form attached to the notice of annual general meeting and the proxy statement as Appendix 1 (the Second Amended MAA), be adopted in substitution for and to the exclusion of the existing memorandum and articles of association of the Company in its entirety with effect upon the Authorised Share Capital Changes taking effect.

Share repurchase and issuance

Shareholders resolved by an ordinary resolution that, subject to the Authorised Share Capital Changes and Second Amended MAA taking effect and the Company’s receipt of the consent to repurchase and application for shares duly executed by INSPIRETECH LTD (“INSPIRETECH”), the Board be and is hereby authorised to repurchase 12,250,000 Class A Shares from INSPIRETECH, all of which are fully paid shares, in consideration of and out of the proceeds of the Company’s new issuance of 12,250,000 Class B Shares to INSPIRETECH. The arrangement effectively converts part of INSPIRETECH’s holding into high‑vote shares while keeping the number of shares held by that shareholder unchanged.

Share consolidation

Shareholders resolved by an ordinary resolution that, following the Authorised Share Capital Changes, and conditional upon the approval of the Board, with effect on a date within one (1) calendar year after the conclusion of the Meeting to be determined by the Board:

(d) every one thousand (1,000) then issued and unissued Class A Shares, or such lesser whole share amount of not being less than two (2) as the Board may determine in its sole discretion, be consolidated into one (1) class A ordinary share (the Consolidated Class A Share(s)), where such Consolidated Class A Shares shall rank pari passu in all respect with each other and have the same rights and are subject to the same restrictions (save as to par value) as the existing Class A Shares as set out in the Second Amended MAA;

(e) every one thousand (1,000) then issued and unissued Class B Shares, or such lesser whole share amount of not being less than two (2) as the Board may determine in its sole discretion, be consolidated into one (1) class B ordinary share (the Consolidated Class B Share(s)), where such Consolidated Class B Shares shall rank pari passu in all respect with each other and have the same rights and are subject to the same restrictions (save as to par value) as the existing Class B Shares as set out in the Second Amended MAA;

(collectively, the Share Consolidation)

(f) all fractional entitlements to the issued Consolidated Class A Shares and Consolidated Class B Shares resulting from the Share Consolidation will not be issued to the shareholders of the Company and instead, any fractional shares that would have resulted from the Share Consolidation will be rounded up to the next whole number; and

(g) the Board be authorised and directed to do all such acts and things as it may consider necessary or desirable for the purpose of effectuating the Share Consolidation, including determining the definitive ratio and the effective date of the Share Consolidation and any other changes to the Company’s authorised share capital in connection with and as necessary to effect the Share Consolidation.

Amendment of Memorandum and Articles of Association reflecting Share Consolidation

Shareholders resolved by a special resolution that subject to and immediately following the Share Consolidation being effected, the relevant provisions of the memorandum and articles of association of the Company then in effect be amended to reflect the Share Consolidation.

The AGM was held on 18 March 2026, with shareholders of record as of 3 March 2026 entitled to vote in person or by proxy. Each ordinary share carried one vote at the meeting, and all five resolutions received the requisite majority of votes cast, in line with the board of directors’ unanimous recommendation.

About Ping An Biomedical Co., Ltd

Ping An Biomedical Co., Ltd. is a one-stop SCM service provider in the apparel industry. It is also a forward-thinking company dedicated to delivering innovative solutions in healthcare and biomedical technology.

For more information, please contact:

Ping An Biomedical Co., Ltd.
Email: corpsec@pingan365.vip

Celestia Investor Relations
Email: investors@celestiair.com

FAQ

What did PASW shareholders approve at the March 18, 2026 AGM?

Shareholders approved five resolutions to amend authorised capital, adopt a revised MAA, convert shares for INSPIRETECH, and approve a share consolidation. According to the company, all five resolutions received the requisite majority of votes.

What is the new authorised share capital and share counts for PASW after the AGM?

Authorised capital becomes US$312,500 divided into 4,900,000,000 Class A and 100,000,000 Class B shares. According to the company, the change takes immediate effect upon the resolutions.

What are the voting rights of the new PASW Class B shares?

Each Class B share is entitled to 100 votes per share, versus one vote for Class A. According to the company, the Class B voting entitlement is explicit in the amended share structure.

What is the INSPIRETECH share exchange approved by PASW shareholders?

The board may repurchase 12,250,000 Class A shares from INSPIRETECH in consideration of issuing 12,250,000 Class B shares to INSPIRETECH. According to the company, this keeps INSPIRETECH's share count unchanged.

When will PASW's 1,000:1 share consolidation take effect and what does it mean?

The share consolidation will take effect on a board-determined date within one year after the meeting, consolidating up to 1,000 pre-consolidation shares into one. According to the company, the board will set the definitive ratio and effective date.